Dr. Reddy's Laboratories Limited
NYSE: RDY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Erez Israeli
- Employees
- 27,048
- Headquarters
- Hyderabad, India
- IPO year
- 2001
- Market cap
- $12.2B
- Website
- https://www.drreddys.com
Loading RDY…
Loading profile data…Frequently asked questions about RDY
What does Dr. Reddy's Laboratories Limited (RDY) do?
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical pr...
Where does RDY trade?
Dr. Reddy's Laboratories Limited (RDY) trades on the New York Stock Exchange.
What sector is RDY in?
Dr. Reddy's Laboratories Limited (RDY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Dr. Reddy's Laboratories Limited?
Erez Israeli is the chief executive officer of Dr. Reddy's Laboratories Limited (RDY).
Where is Dr. Reddy's Laboratories Limited headquartered?
Dr. Reddy's Laboratories Limited is headquartered in India.
Does RDY pay a dividend?
Yes — Dr. Reddy's Laboratories Limited (RDY) paid a trailing twelve-month dividend of USD 0.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did RDY go public?
Dr. Reddy's Laboratories Limited (RDY) completed its initial public offering in 2001.
Is RDY an ADR?
Yes — RDY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Dr. Reddy's Laboratories Limited reporting and dividends follow the underlying issuer.